International Plasma Protein Congress

IPPC logo 2019 01

Every year, policymakers, regulators, industry leaders, physicians, scientists, and patient representatives from around the globe come together for the plasma protein therapeutics industry's premier European event the International Plasma Protein Congress (IPPC).

Save the date! IPPC 2020 will be held 1-2 October in Berlin.




 0830-0900 Opening
Amy Efantis, President & CEO — PPTA

Keynote address
Martin Seychell, EU Commission, Deputy Director General, DG SANTE   (TBC)

0900-1045 Session 1 : Europe needs more plasma: Challenges and solutions
Chair: Peter O'Donnell, Freelance reporter — APM news / Politico


Miguel-Angel Vesga Carasa, Director General — Basque Transfusion Center, Spain  (TBC)

Matthew Hotchko, President — The Marketing Research Bureau

Nizar Mahlaoui, Pediatrician — Necker University Hospital for Children with Rare Disease, Paris (TBC)

Marie-Laure Hecquet, Head of the HealthCare Section — European Directorate for the Quality of Medicines & Healthcare (EDQM - Council of Europe), Department of Biological Standardisation (TBC)

Jose Drabwell, President — International Patient Organisation for Primary Immunodeficiencies (IPOPI)

Stefaan van der Spiegel, Head of Sector, Substances of Human Origin — DG for Health and Food Safety (SANTE), European Commission

Martina Brix-Zuleger, Commissioner, Department VIII/C/1 Blood, Tissues and Cells — Austrian Ministry of Health   (TBC)

Matthias Gessner, Chair European Plasma Alliance, Head Takeda BioLife Plasma Europe Operations

1045-1130 Networking Break
1130-1300 Session 2: Plasma Collection: A German success story
Chair: Stephan Walsemann,
Managing Director & Medical Director — Scinomed Germany (Former Chair of the European Plasma Alliance) (TBC)

Dagmar Dörmann — German Ministry of Health, Unit 113, Blood and Blood Products, Sera, Vaccines and Tissues (TBC)

Franz Weinauer, Managing Director, Blood Collection Service — Bavarian Red Cross (TBC)

Andrea Maier-Neuner, General Manager — dsai (Deutsche Selbsthilfe angeborene Immundefekte) [German PID patient group] (TBC)

Svenja Tatjana Barckhausen, Senior Director, Plasma Alliance Operations and Protein Procurement — Biotest

1300-1415 Networking Lunch
1415-1545 Session 3: Access to Care in Europe
Chair: Brian Maguire, Journalist / Producer — Euractiv 

Lieven Annemans, Senior Professor in Health Economics — Ghent University

Philippe Van Wilder, Professor in health economics and HTA — Ecole de Santé Publique — Université Libre de Bruxelles

Martine Pergent, President — IPOPI

Adrian Górecki, President & Founder —

Marianna Cavazza — University Bocconi, Italy (TBC)

Tomasz Kluszczynski, Consultant — Vintura

Maarten Van Baelen, Executive Director Europe — PPTA

1545-1615 Networking Break
1615-1730 Session 4: Hemophilia Care in Europe: “Care for Rare”
Chair: Sibylle Barden, Executive Director Barden Publishing (TBC)

Tobias Becker — IGH (Interessengeinschaft Hämophiler) (TBC)

Marion Wilkens, President — Alpha1 Deutschland (TBC)

Birgit Schlennert, General Manager — dsai [German PID patient group] (TBC)

Christine Keipert, Head of the Office of the German Hemophilia Registry, Section Coagulation Products — Paul-Ehrlich-Institut (PEI) (TBC)

Volker Wahn, Senior Consultant, Department of Pediatrics — Charité, Berlin (TBC)

Alessandro Gringeri, Chief Medical and R&D Officer — Kedrion (TBC)

1730-1740 Closing remarks
Karen Etchberger, Chair, PPTA Global Board of Directors; Head of Digital Transformation & Execution Systems — CSL Behring (TBC)
1740-1750 Presentation of the HILFENHAUS AWARD
1750-1915 Networking Reception


 0900-0930  Opening

Oliver Schmitt, Chair, PPTA European Board of Directors; General Manager — CSL Behring (TBC)

Keynote address
François-Xavier Lery, Coordinator for Technologies, Standards and Norms — World Health Organization (TBC)

0930-1045 Session 5: Innovation
Chair: Dominika Misztela, Senior Director, Regulatory Policy Europe — PPTA

Research and innovation in the EU — Set-up and possible links to blood and blood components
Stefaan van der Spiegel, Head of Sector, Substances of Human Origin — DG for Health and Food Safety (SANTE), European Commission

The untapped potential of plasma-derived proteins   (Sponsored presentation)
Bagirath Gangadharan, Head of Translational Research — Takeda (TBC)
Andreas Liebminger, Head of Pharmaceutical Sciences and Devices — Takeda  (TBC)

Technical innovations for large-scale plasma processing     (Sponsored presentation)
Dieter Fassnacht — Senior Director — Grifols Process Engineering  (TBC)

Innovation in Primary Immune Deficiencies: The vision of patients
Andrea Gressani, Vice President — Associazone Immunodeficienze Primitive (TBC)

1045-1130 Networking Break
1130-1300 Session 6:  Hyperimmune globulins in Germany, Europe and beyond - needs, policies, manufacturing and the future
Chairs: Giuseppe Buonocore, Professor and Chairman of Paediatrics and Neonatology  University of Siena (TBC)
Larisa Cervenakova, Medical Director  PPTA

Worldwide Initiative for Rh Disease Eradication: WIRhE
Giuseppe Buonocore, Professor and Chairman of Paediatrics and Neonatology — University of Siena (TBC)

Hyperimmunoglobulins: A European dilemma from a German perspective
Uta Buckpesch-Heberer, Senior Clinical Assessor, Polyclonal and Monoclonal Antibodies — Paul-Ehrlich-Institut (PEI) (TBC)

Specific Immune Globulins to Prevent or Treat Infectious Diseases: Manufacturing Considerations and Challenges
Dorothy Scott, Supervisory Medical Officer & Chief, Plasma Derivatives Branch, Division of Plasma Protein Therapeutics, OTAT — U.S. Food and Drug Administration (TBC)

Hyperimmunes in Europe: Perspectives from a North American Hyperimmune manufacturer
Angela Dyer, Vice President, Regulatory Affairs — Emergent BioSolutions Canada (TBC)

Emerging viruses, and hyperimmune plasma products for prevention and treatment of infectious diseases
Thomas R. Kreil, Associate Professor of Virology; Vice President, Global Pathogen Safety — Takeda (TBC)

1300-1400 Networking Lunch
1400-1430 Another Emerging Virus, SARS-CoV-2: What is Known, and What Not (Yet)
Thomas R. Kreil, Associate Professor of Virology; Vice President, Global Pathogen Safety — Takeda (TBC)
1430-1445 Closure of IPPC 2020
Maarten Van Baelen, Executive Director Europe — PPTA

[Program and speakers are subject to change]

Additional Information

Alpha 1 Foundation 25th logo AFNP Logo QUAD EPODIN
IPOPI signature PIDUK logo strap1 WFH logo EN RGB highres 

Congress Contacts

Hotel and Congress

Melanie Conrads or +32.2.724.0188

Charon Smith or +1.443.433.1114
Sponsorship and Exhibit 
Michelle Mason or +1.443.433.1106
Copyright © 2020 PPTA. All rights reserved. (202) 789-3100